These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 23460970)
1. [Synthesis and biological evaluation of tetrahydrocoptisine quaternary ammonium compounds]. Wang DM; Wei JZ; Fan BY; Liu Q; Zhu HB; Shen ZF; Wu S Yao Xue Xue Bao; 2012 Dec; 47(12):1640-5. PubMed ID: 23460970 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and antihyperglycemic evaluation of various protoberberine derivatives. Bian X; He L; Yang G Bioorg Med Chem Lett; 2006 Mar; 16(5):1380-3. PubMed ID: 16359864 [TBL] [Abstract][Full Text] [Related]
3. Discovery of tetrahydrocarbazoles with potent hypoglycemic and hypolipemic activities. Zhang JQ; Li SM; Ma X; Zhong G; Chen R; Li XS; Zhu GF; Zhou B; Guo B; Wu HS; Tang L Eur J Med Chem; 2018 Apr; 150():102-112. PubMed ID: 29525431 [TBL] [Abstract][Full Text] [Related]
4. Flavone-based novel antidiabetic and antidyslipidemic agents. Verma AK; Singh H; Satyanarayana M; Srivastava SP; Tiwari P; Singh AB; Dwivedi AK; Singh SK; Srivastava M; Nath C; Raghubir R; Srivastava AK; Pratap R J Med Chem; 2012 May; 55(10):4551-67. PubMed ID: 22524508 [TBL] [Abstract][Full Text] [Related]
5. Microwave-assisted synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-Amino-6-(4-substituted phenyl)-pyrimidin-4-yl)-phenoxy)-2-methyl propanoic acid derivatives. Mokale SN; Elgire RD; Sakle NS; Shinde DB Arch Pharm (Weinheim); 2012 Jan; 345(1):22-7. PubMed ID: 22076967 [TBL] [Abstract][Full Text] [Related]
7. Antihyperglycemia and Antihyperlipidemia Effect of Protoberberine Alkaloids From Rhizoma Coptidis in HepG2 Cell and Diabetic KK-Ay Mice. Ma H; Hu Y; Zou Z; Feng M; Ye X; Li X Drug Dev Res; 2016 Jun; 77(4):163-70. PubMed ID: 27045983 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, hypoglycaemic, hypolipidemic and PPARγ agonist activities of 5-(2-Alkyl/aryl-6-Arylimidazo[2,1-b][1,3,4]thiadiazol-5-yl)methylene-1,3-thiazolidinediones. Khazi MI; Belavagi NS; Kim KR; Gong YD; Khazi IA Chem Biol Drug Des; 2013 Aug; 82(2):147-55. PubMed ID: 23581650 [TBL] [Abstract][Full Text] [Related]
9. Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents. Raza S; Srivastava SP; Srivastava DS; Srivastava AK; Haq W; Katti SB Eur J Med Chem; 2013 May; 63():611-20. PubMed ID: 23567949 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-substituted aminothiazole-4-yl) phenoxy)-2-methyl propanoic acid derivatives. Mokale SN; Elgire RD; Sakle N; Shinde DB Bioorg Med Chem Lett; 2011 Jan; 21(2):682-5. PubMed ID: 21193309 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of some novel cyclic-imides as hypoglycaemic, anti-hyperlipidemic agents. Abdel-Aziz AA; El-Azab AS; Attia SM; Al-Obaid AM; Al-Omar MA; El-Subbagh HI Eur J Med Chem; 2011 Sep; 46(9):4324-9. PubMed ID: 21783284 [TBL] [Abstract][Full Text] [Related]
12. Dose-related antihyperglycemic and hypolipidemic effects of two novel thiazolidin-4-ones in a rodent model of metabolic syndrome. Karot SS; Surenahalli VG; Kishore A; Mudgal J; Nandakumar K; Chirayil MT; Mathew G; Nampurath GK J Diabetes; 2016 Sep; 8(5):629-39. PubMed ID: 26345135 [TBL] [Abstract][Full Text] [Related]
13. Discovery of C-9 Modified Berberine Derivatives as Novel Lipid-Lowering Agents. Li DD; Yu P; Xu H; Wang ZZ; Xiao W; Zhao LG Chem Pharm Bull (Tokyo); 2021 Jan; 69(1):59-66. PubMed ID: 33087641 [TBL] [Abstract][Full Text] [Related]
14. Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents. Sohda T; Mizuno K; Momose Y; Ikeda H; Fujita T; Meguro K J Med Chem; 1992 Jul; 35(14):2617-26. PubMed ID: 1635060 [TBL] [Abstract][Full Text] [Related]
15. Antihyperglycemic and antihyperlipidemic effects of newly synthesized glibenclamide analogues on streptozotocin-diabetic rats. Ahmadi A; Khalili M; Farsadrooh M; Ghiasi M; Nahri-Niknafs B Drug Res (Stuttg); 2013 Dec; 63(12):614-9. PubMed ID: 23828271 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of alkaloids by Stevens rearrangement of nitrile-stabilized ammonium ylides: (±)-laudanosine, (±)-laudanidine, (±)-armepavine, (±)-7-methoxycryptopleurine, and (±)-xylopinine. Orejarena Pacheco JC; Lahm G; Opatz T J Org Chem; 2013 May; 78(10):4985-92. PubMed ID: 23634947 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vivo screening of some novel quinazoline analogs as anti-hyperlipidemic and hypoglycemic agents. Mokale SN; Palkar AD; Dube PN; Sakle NS; Miniyar PB Bioorg Med Chem Lett; 2016 Jan; 26(2):272-276. PubMed ID: 26707395 [TBL] [Abstract][Full Text] [Related]
18. Novel thieno oxazine analogues as antihyperglycemic and lipid modulating agents. Das SK; Reddy KA; Abbineni C; Iqbal J; Suresh J; Premkumar M; Chakrabarti R Bioorg Med Chem Lett; 2003 Feb; 13(3):399-403. PubMed ID: 12565938 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and hypoglycemic activity of 9-O-(lipophilic group substituted) berberine derivatives. Zhang S; Wang X; Yin W; Liu Z; Zhou M; Xiao D; Liu Y; Peng D Bioorg Med Chem Lett; 2016 Oct; 26(19):4799-4803. PubMed ID: 27561717 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, hypoglycemic and hypolipidemic activities of novel thiazolidinedione derivatives containing thiazole/triazole/oxadiazole ring. Mohammed Iqbal AK; Khan AY; Kalashetti MB; Belavagi NS; Gong YD; Khazi IA Eur J Med Chem; 2012 Jul; 53():308-15. PubMed ID: 22575535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]